Results for komplement translation from Maltese to English

test ta' fissazzjoni tal-komplement
complement fixation test

rari: fattur tal-komplement mhux normali.
complement factor abnormal.

awto- antikorpi pożittivi, anormailtà fill- fattur tal- komplement
autoantibody positive, complement factor abnormal

huwa appoġġjat attivament mill-kummissjoni bħala alternattiva jew komplement għal-leġiżlazzjoni23.
it is actively supported by the commission as an alternative or complement to legislation23.

tfal u adolexxenti b’defiċjenzi tal-komplement, asplenja jew disfunzjoni tal-milsa
children and adolescents with complement deficiencies, asplenia, or splenic dysfunction

din ir-rakkomandazzjoni hija għalhekk komplement utli, li tibgħat messaġġ ċar lill-istati membri.”
this recommendation is therefore a useful complement, sending a clear message to member states.”

5.1 ix-xogħol b’paga u x-xogħol ekonomikament dipendenti: kompetizzjoni jew komplement?
5.1 waged work and economically dependent work: competition or complement?

5.1 ix-xogħol b’paga u x-xogħol awtonomu ekonomikament dipendenti: kompetizzjoni jew komplement?
5.1 waged work and economically dependent self-employed work: competition or complement?

dak li tista’ tagħmel l-ue dwar il-kwistjonijiet soċjali huwa komplement żgħir għall-politiki soċjali nazzjonali.
what the eu can do on social issues is only a small complement to national social policies.

huma m'għandhomx jagħtu twaħħil tal-komplement ma' xi platelets magħrufa li ma jkunx fihom dan l-antiġen jew antiġeni.
they must not give complement fixation with any platelets known not to contain this antigen (these antigens).

reaġenti użati biex ikunu kklassifikati tessuti umani għall-użu f'teknika ta' twaħħil ta' komplement ma' platelets
tissue-typing reagents for use in a complement fixation technique on platelets

antikorpi kontra l-kapsula tal-meningokokkus jipproteġu kontra mard tal-meningokokkus permezz ta’ attività batteriċida medjata mill-komplement.
anti-capsular meningococcal antibodies protect against meningococcal diseases via complement mediated bactericidal activity.

barra dan, in vivo, obinutuzumab jikkaġuna grad baxx ta’ ċitotossiċità dipendenti fuq il-komplement (cdc - complement dependent cytotoxicity).
in addition, in vivo, obinutuzumab mediates a low degree of complement dependent cytotoxicity (cdc).

soliris għalhekk irodd ir - regolazzjoni tal- komplement terminali fid- demm ta 'pazjenti pnh u jimpedixxi l- emolisi intravaskulari medjata mill- komplement terminali f' pazjenti pnh.
soliris therefore restores terminal complement regulation in the blood of pnh patients and inhibits terminal complement mediated intravascular haemolysis in pnh patients.